Can Wegovy Stop Your Period — or Change Your Cycle?

The misconception: Wegovy targets your cycle directly

A common worry (and one our prescribers hear fairly regularly) is that Wegovy itself switches off menstruation. That is not how the medicine works. Semaglutide is a GLP-1 receptor agonist: it acts on receptors involved in appetite regulation and blood glucose, slowing gastric emptying and reducing hunger signals. It has no direct pharmacological effect on the pituitary-ovarian axis that drives your monthly cycle. If your periods stop or become irregular after starting Wegovy, the medicine is almost certainly not acting on your reproductive hormones in isolation.

The actual picture is more nuanced. Weight itself is a powerful hormonal signal. Body fat stores produce and convert oestrogen, and when fat mass falls quickly, oestrogen levels can shift enough to disrupt the hormonal cascade your body uses to trigger ovulation. This is the same mechanism that causes missed periods in people who lose weight through diet and exercise alone. Wegovy accelerates weight loss for many people, which makes that disruption more likely, and may make it happen faster than it would otherwise. You can read more about how semaglutide works in the body on the semaglutide overview page.

Does Wegovy stop your period, or does weight loss?

In clinical trials, Wegovy was not specifically designed to measure menstrual outcomes, so there is no large randomised dataset isolating cycle changes in the way there is for weight loss or cardiovascular risk. What clinicians draw on is the well-established relationship between substantial weight loss and hypothalamic disruption of the menstrual cycle, alongside post-market reports from people using GLP-1 medicines.

The pattern that emerges is consistent with weight-driven hormonal change rather than a drug-specific effect. Missed or delayed periods tend to be reported by people who lose weight quickly, particularly in the first few months of treatment. People who lose weight more gradually tend to report fewer disruptions. Periods often return to their previous pattern once weight stabilises, which again points to weight change as the driver. The detailed page on Wegovy and cycle changes covers the full range of effects reported, including spotting and shortened cycles. If you want broader context on the relationship between semaglutide and menstruation, the semaglutide and periods page addresses the same question across both Ozempic and Wegovy users.

One practical note: if you keep your Wegovy pen in the fridge door and you are tracking your cycle, put a reminder in your phone alongside your weekly injection day. Cycle changes are worth logging so you can give your prescriber an accurate picture if you need to discuss it.

When Wegovy might actually improve periods (PCOS and related conditions

For some people, Wegovy does not disrupt periods at all) it regularises them. This matters especially for people with polycystic ovary syndrome. PCOS is strongly associated with insulin resistance and excess androgen levels, both of which are influenced by body weight. Weight reduction in people with PCOS can restore more regular ovulation and reduce the androgenic hormonal excess that causes irregular cycles. Because Wegovy can produce substantial, sustained weight loss, it may indirectly improve cycle regularity for this group, the opposite of stopping periods.

The page specifically about Wegovy and menstruation goes into this in more detail. UK guidance on weight-management injections, published by NHS England, also notes the interaction between weight change and reproductive hormones in the context of GLP-1 therapy, worth reading if you want the clinical framing rather than patient-forum accounts. Crucially, a prescriber can look at your individual history and tell you what to watch for; that assessment is part of what a Wegovy consultation covers. The broader Wegovy treatment page explains eligibility and how the clinical process works.

Contraception: the practical point most people miss

One thing that does deserve clear attention: reduced periods or cycle disruption does not mean you cannot conceive. Wegovy is not recommended during pregnancy, and the MHRA advises using effective contraception while taking it. The page on absent periods on Wegovy addresses this directly, but the short answer is this: an irregular or missed period is not the same as infertility, and an unplanned pregnancy while on Wegovy would require you to stop treatment promptly and seek obstetric advice.

If you use oral contraceptive pills, the absorption question is worth raising with your prescriber. NHS England guidance notes that for tirzepatide (Mounjaro, not Wegovy), a non-oral contraceptive method should be added for the first four weeks and after each dose increase, because gastric emptying changes can reduce pill absorption. The evidence for semaglutide is less definitive, but if you have any concern, discussing it at your consultation takes about thirty seconds and removes the uncertainty entirely. The free consultation with our prescribers is the place to raise exactly these kinds of questions, you can mention your contraception, your cycle history, and any other medicines you take, and a real clinician will review your answers the same day. For context on Wegovy treatment costs, that page gives a clear breakdown of what private treatment includes.

NHS guidance from NHS England on weight-management injections is a reliable reference for contraception and hormonal considerations during GLP-1 treatment. For side-effect reporting, including any unexpected menstrual changes, the MHRA Yellow Card scheme lets patients report directly and contributes to ongoing safety monitoring of these medicines.